AI disease modelling startup CytoReason to scale up in US
The company aims to reach more biotech and pharma companies, increase the speed and accuracy of drug development and benefit patients.
The company aims to reach more biotech and pharma companies, increase the speed and accuracy of drug development and benefit patients.